Metabolic tumor constitution is superior to tumor regression grading for evaluating response to neoadjuvant therapy of esophageal adenocarcinoma patients

Corresponding Author

Institute of Pathology, University of Bern, Bern, Switzerland

Institute of Clinical Pathology and Molecular Pathology, Kepler University Hospital and Johannes Kepler University, Linz, Austria

These authors share the last authorship

Correspondence to: A Walch, Research Unit Analytical Pathology, Helmholtz Zentrum München – German Research Center for Environmental Health, Ingolstädter Landstraße 1, Neuherberg, 85764, Germany. E-mail: axel.walch@helmholtz-muenchen.de; or

R Langer, Institute of Clinical Pathology and Molecular Pathology, Kepler University Hospital, Krankenhausstr. 9, 4021 Linz, Austria.

E-mail: rupert.langer@kepleruniklinikum.at

Search for more papers by this author

留言 (0)

沒有登入
gif